Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
16.42
+0.23 (1.42%)
At close: Jul 3, 2025, 1:00 PM
17.36
+0.94 (5.72%)
After-hours: Jul 3, 2025, 3:43 PM EDT
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $421.80 million as of July 3, 2025. Its market cap has increased by 9.35% in one year.
Market Cap
421.80M
Enterprise Value
172.69M
1-Year Change
9.35%
Ranking
Category
Stock Price
$16.42
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $421.80M, an increase of 90.28%. That is a compound annual growth rate of 45.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 421.80M | -18.89% |
| Dec 31, 2024 | 520.03M | -2.33% |
| Dec 29, 2023 | 532.42M | 140.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 306.47B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 238.56B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 216.08B |